Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2024-12-11 00:00:00 ET · period of report 2024-12-10 · accession 0001628280-24-050787 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-11 | 2024-12-10 | MYGN | Davis Mark Steven | Dir | A - Grant | $0.00 | +22.8K | 22.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-10 | A | A | 22,816 | $0.00 | 22,816 | D | — | — | (F1) Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. |